Document is current
Any future updates will be listed below
-
Authors
Seecheran, Naveen https://orcid.org/0000-0002-7779-0181
Grimaldos, Kathryn
McCallum, Penelope
Ramcharan, Priya
Kawall, Jessica
Katwaroo, Arun
Grimaldos, Gabriella
Seecheran, Valmiki
Jagdeo, Cathy-Lee
Rafeeq, Salma
Seecheran, Rajeev
Leyva Quert, Abel
Ali, Nafeesah
Peram, Lakshmipathi
Motilal, Shastri
Ramtahal, Rishi
Bhagwandass, Neal
Giddings, Stanley
Ramlackhansingh, Anil
Sandy, Sherry
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06567678 at ClinicalTrials.govDocuments that mention this clinical trial
The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study
https://doi.org/10.1007/s40119-024-00393-2
-
Funding
Funding for this research was provided by:
University of the West Indies, St. Augustine Campus (CRP.3.MAR24.10)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 4 December 2024
First Online: 18 January 2025
Declarations
:
: Naveen Seecheran is an Editorial Board member of Cardiology and Therapy. Naveen Seecheran was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. Kathryn Grimaldos, Penelope McCallum, Priya Ramcharan, Jessica Kawall, Arun Katwaroo, Gabriella Grimaldos, Valmiki Seecheran, Cathy-Lee Jagdeo, Salma Rafeeq, Rajeev Seecheran, Abel Leyva Quert, Nafeesah Ali, Lakshmipathi Peram, Shastri Motilal, Rishi Ramtahal, Neal Bhagwandass, Stanley Giddings, Anil Ramlackhansingh, and Sherry Sandy have nothing to disclose with respect to personal, financial, commercial, or academic conflicts of interest.
: The study complied accordingly with the Declaration of Helsinki, International Conference on Harmonization, Good Clinical Practice (ICH-GCP), and was authorized by the Campus Research Ethics Committee (CREC) of the University of the West Indies, St. Augustine (UWI STA), Trinidad (CREC-SA.2525/02/2024). All patients with stable CAD on DAPT consented (written, triplicate) to participate in a prospective, open-label, single-arm pharmacodynamic study that evaluated the effect of colchicine (COLC) [Strides Pharma UK Limited, Watford Hertfordshire, England] 0.5 mg administered orally once daily for 14 days on platelet reactivity with respect to aspirin reaction units (ARUs) and P2Y12 reaction units (PRUs).
